First-in-human clinical trial to test CAR T cell therapy for pediatric gliomas
The Phase 1 clinical trial is expected to enroll up to 18 children between 4 and 18 years old with pediatric high-grade gliomas.
Posts tagged as
Glioma
UF researcher launches novel immunotherapy trial for pediatric cancers
The trial will test a novel UF-developed mRNA lipid nanoparticle (RNA-LP) in two pediatric cancers.
